Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

31 Aug 2020 --- Nestlé Health Science (NHSc) has entered into a definitive agreement to acquire Aimmune Therapeutics, which is a biopharmaceutical company developing... Read More

FormattedPicture

BUSINESS NEWS

14 Aug 2020 --- This week in nutrition news, Glanbia acquired Foodarom in a move to expand its flavor capabilities. Meanwhile, Stratum Nutrition and Atacama Bio entered a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 Aug 2020 --- Many allergies and food sensitivities are on the rise, with some consumers flagging difficulties digesting many dairy products, for example. As a result, industry... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

31 Jul 2020 --- Nestlé’s infant nutrition subsidiary Gerber is expanding its organic snacks range with the introduction of Gerber Organic BabyPops. The product is a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Jul 2020 --- Collagen and lactose-free A2/A2 dairy are new features of Re:THINK Ice Cream’s products, as the US-based company rethinks both its formulation and branding in... Read More

trans